Making High Throughput Natural Product Discovery Possible
Natural products are chemicals produced by microbes that have important applications as the active ingredients in specialty chemical products ranging from pharmaceuticals to herbicides.
Our Mission at MicroMGx is to accelerate the discovery of new chemistry from nature that can enrich and extend human life.
Our Vision is that all undiscovered compounds produced by microbes will be identified and made accessible to life science R&D organizations around the world.
What exactly are Natural Products?
We discover Natural Products here at MicroMGx. But, what exactly ARE Natural Products? Why is it hard to discover them? What makes MicroMGx special?
We are constantly asked these questions and have designed a short 2.5 min video to answer them. We hope you find it educational and interesting!
Making High Throughput Natural Product Discovery Possible
Natural products are chemicals produced by microbes that have important applications as the active ingredients in specialty chemical products ranging from pharmaceuticals to herbicides.
Our Mission at MicroMGx is to accelerate the discovery of new chemistry from nature that can enrich and extend human life.
Our Vision is that all undiscovered compounds produced by microbes will be identified and made accessible to life science R&D organizations around the world.
What exactly are Natural Products?
We discover Natural Products here at MicroMGx. But, what exactly ARE Natural Products? Why is it hard to discover them? What makes MicroMGx special?
We are constantly asked these questions and have designed a short 2.5 min video to answer them. We hope you find it educational and interesting!
News & Events
Big Day at Micromgx for Our Followers and Our Team Members
On Friday, September 2nd, our Crowdfunding site went LIVE! If you ever have read about exciting startup companies but are not an angel investor or venture capitalist, you are normally out of luck. But now, MicroMGx has [...]
MicroMGx’s CEO, Jack Kloeber, talks about De-risking Biologicals at Gener8tor’s OnRamp AGTech conference
MicroMGx’s CEO, Jack Kloeber, spoke as an invited panelist during Gener8tor’s OnRamp AGTech conference, held for the first time in Champaign, Illinois, from 25-26 July, 2022. Sara Olson, FMC Ventures and Brennan Duty, Ginkgo Bioworks joined Jack [...]
MicroMGx Chosen as a Finalist in UPL’s Radicle Carbon & Soil Challenge
Actinobacteria is a phylum of Gram-positive bacteria with high guanine and cytosine content in their DNA. Although understood primarily as soil bacteria, they might be more abundant in freshwaters. Considered to be one of the most prolific [...]
News & Events
Big Day at Micromgx for Our Followers and Our Team Members
On Friday, September 2nd, our Crowdfunding site went LIVE! If you ever have read about exciting startup companies but are not an angel investor or venture capitalist, you are normally out of luck. But now, MicroMGx has [...]
MicroMGx’s CEO, Jack Kloeber, talks about De-risking Biologicals at Gener8tor’s OnRamp AGTech conference
MicroMGx’s CEO, Jack Kloeber, spoke as an invited panelist during Gener8tor’s OnRamp AGTech conference, held for the first time in Champaign, Illinois, from 25-26 July, 2022. Sara Olson, FMC Ventures and Brennan Duty, Ginkgo Bioworks joined Jack [...]
MicroMGx Chosen as a Finalist in UPL’s Radicle Carbon & Soil Challenge
Actinobacteria is a phylum of Gram-positive bacteria with high guanine and cytosine content in their DNA. Although understood primarily as soil bacteria, they might be more abundant in freshwaters. Considered to be one of the most prolific [...]
MicroMGx partners with Corteva Agriscience to Expand Use of Natural Products Discovery for Crop Protection
MicroMGx is expanding the use of its metabologenomics natural product discovery platform to mine fungi for new sustainable crop protection products at an industrial scale. “Our platform is the first ever that can deliver new natural products [...]
Corteva Agriscience Innovates for New Sustainable Products with MicroMGx Natural Products Discovery Platform
MicroMGx, Inc., a life sciences company dedicated to making high-throughput natural product discovery achievable, today announced an expanded agreement focused on accelerating natural products discovery with pure-play global agriculture company Corteva Agriscience. Read announcement: https://www.micromgx.com/micromgx-partners-with-corteva-agriscience-to-expand-use-of-natural-products-discovery-for-crop-protection/ Actinobacteria [...]
MicroMGx accelerating new product development by making natural products discovery more efficient.
Microorganisms have evolved the ability to produce complex molecules known generally as natural products (or secondary metabolites) that include numerous high-value compounds with applications in the food, agricultural, chemical, and pharmaceutical industries. Discovering these high-value natural products [...]
MicroMGx drives increased new product development for leaders in the agriculture space using largescale new product discovery
The leading agriscience companies are looking to innovation and natural products discovery for a more effective and efficient way to increase new product development, product effectiveness and growth. Genome mining has emerged in the past decade as [...]
MicroMGx announces research collaboration agreement with Elanco to investigate animal-health promoting microorganisms
Chicago, IL – June 24, 2021 Today MicroMGx, Inc. announces it has initiated a collaboration with Elanco Animal Health Inc to discover novel animal health products based on or derived from microorganisms. Under the agreement, MicroMGx will use its MGx technology platform to profile microorganisms that have [...]
MicroMGx Welcomes Dr. Joseph Byrum to the Team
Written by our CEO Jack Kloeber: "I am very happy to announce that Dr. Joseph Byrum will be joining our Scientific and Industry Advisory Board. I have personally known Joe for 9 years and during that time [...]
MicroMGx Welcomes Dr. Richard Baltz to the Team
We are proud to announce that Richard Baltz has joined MicroMGx as a Scientific Advisor. Dr. Baltz is a both a pioneer and thought leader in #naturalproducts discovery. He led the Eli Lilly Molecular Genetics department and helped establish Lilly as a world [...]
MicroMGx Welcomes Dr. Alph Bingham to the Team
We are extremely happy to announce that the renowned innovation guru, Dr. Alph Bingham, has joined our advisory team. His experience of over 25 years in R&D roles with Eli Lilly, the many startups he has founded, [...]
MicroMGx Welcomes Dr. Raj Pannu to the Team
We are extremely excited, during this period of growth and expansion, to welcome Dr. Raj Pannu to our Board of Directors. Raj is a practicing vascular specialist in Westerville, OH. He is one of a select few [...]
Congratulations to Prof. Neil Kelleher, MicroMGx’s Chairman of the Board, who co-authored a published article in ACS Chemical Biology
Prof. Neil Kelleher, MicroMGx’s Chairman of the Board, co-authored a published article in ACS Chemical Biology, 2020, again showing the efficacy of using the metabologenomics platform to identify new bioactive compounds and a new biosynthetic gene cluster. Learn [...]
Corteva and MicroMGx Collaborate to Accelerate the Development of Microbial-Based Crop Protection Products
INDIANAPOLIS, Ind., Oct. 8, 2019 — Corteva Agriscience and MicroMGx today announced a collaboration that aims to provide farmers a wider range of novel, microbial-based crop protection products. Under the agreement, MicroMGx will apply its metabologenomics platform [...]
Our Process
Our History
MicroMGx (originally named Microbial Pharmaceuticals) was co-founded in 2015 by Northwestern University Professors Neil Kelleher and Regan Thomson and University of Illinois Professor William Metcalf. The Chief Scientific Officer of MicroMGx, Anthony Goering, PhD, discovered the first novel, active compound using MicroMGx’s cutting-edge technology platform.
Metabologenomics is the core of MicroMGx’s natural product discovery platform, developed over a decade-long collaboration between the co-founding Professors. MicroMGx began operations in 2017 with an award from the Small Business Innovation Reward (SBIR) program of the National Institutes for Health.
Our History
MicroMGx (originally named Microbial Pharmaceuticals) was co-founded in 2015 by Northwestern University Professors Neil Kelleher and Regan Thomson and University of Illinois Professor William Metcalf. The Chief Scientific Officer of MicroMGx, Anthony Goering, PhD, discovered the first novel, active compound using MicroMGx’s cutting-edge technology platform.
Metabologenomics is the core of MicroMGx’s natural product discovery platform, developed over a decade-long collaboration between the co-founding Professors. MicroMGx began operations in 2017 with an award from the Small Business Innovation Reward (SBIR) program of the National Institutes for Health.
Our History
MicroMGx (originally named Microbial Pharmaceuticals) was co-founded in 2015 by Northwestern University Professors Neil Kelleher and Regan Thomson and University of Illinois Professor William Metcalf. The Chief Scientific Officer of MicroMGx, Anthony Goering, PhD, discovered the first novel, active compound using MicroMGx’s cutting-edge technology platform.
Metabologenomics is the core of MicroMGx’s natural product discovery platform, developed over a decade-long collaboration between the co-founding Professors. MicroMGx began operations in 2017 with an award from the Small Business Innovation Reward (SBIR) program of the National Institutes for Health.
Our Team
Careers
Thank you for your interest in a career at MicroMGx, please email us at info@micromgx.com for more information.
Contact Us
The goal at MicroMGx is to develop the largest, functional library of natural products (through the most robust discovery platform) in order to facilitate a new pipeline of chemical matter into early stage pharmaceutical testing. If you are interested in supporting our mission, or have any type of inquiry, feel free to contact us.
Contact Us
The goal at MicroMGx is to develop the largest, functional library of natural products (through the most robust discovery platform) in order to facilitate a new pipeline of chemical matter into early stage pharmaceutical testing. If you are interested in supporting our mission, or have any type of inquiry, feel free to contact us.
